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ABSTRACT: In-vivo intravital short wavelength infrared (SWIR, 1000 – 2300 nm) 
fluorescence imaging has attracted considerable attention in the imaging of tumor 
vasculature due to its low background, high sensitivity, and deep penetration. It can 
noninvasively provide dynamic feedback on the tumorigenesis, growth, necrosis and 
metastasis. Herein, monodisperse Nd3+-doped core-shell downconversion luminescent 
nanocrystals with strong emission in the second near-infrared (NIR II) window, strong 
temperature-dependent paramagnetism and fast attenuation to X-rays were prepared 
from ultra-small nanoclusters. The use of nanoclusters resulted in very uniform bright 
nanocrystals with a relative quantum yield comparable to the standard dye IR-26. 
These bright NIR nanocrystals were modified with 
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene 
glycol)-2000] to endow with excellent water-solubility, biocompatibility and a blood 
circulation half-life of 5.9 h. They were then successfully used to demonstrate the 
variation of tumor vasculature with tumor progression from tumorigenesis, growth, to 
necrosis in the subcutaneous breast tumor through the NIR II fluorescence imaging. 
They were also used as contrast agent of magnetic resonance imaging (MRI) and 
X-ray computed tomography (CT) imaging of tumor to provide complementary 
anatomic structure. Their great potential in NIR II imaging of tumor was further 
demonstrated with an orthotopic breast tumor. Their in-vivo biosafety was also 
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Tumor vasculature has played significant roles in tumorigenesis, growth and 
metastasis. It not only serves as channels for supplying nutrients and oxygen during 
tumorigenesis and growth, but also acts as pathways for tumor metastasis.[1, 2] The 
variation of tumor vasculature has been used for tumor staging, and considered as an 
important prognostic indicator for evaluating tumor metastasis. For example, a tumor 
with dense vasculature has a higher incidence of metastasis than one with poor 
vasculature.[1, 3] From perspective of diagnosis and treatment, tumor vasculature has 
been extensively used to deliver imaging agents and drugs through the enhanced 
penetration and retention (EPR) effect, which arises from its non-uniform, chaotic, 
and highly permeable features in comparison with a healthy vasculature.[4, 5] It should 
be noted that the tumor vasculature is strongly dependent on the specific properties of 
tumor (e.g., tumor model, tumor size and tumor site).[6] During tumor therapy, the 
variation of tumor vasculature can be used to evaluate the efficacy of treatment.[7, 8]  
The above statements demonstrate the significance of tumor vasculature. It is 
crucial to monitor its formation and variation through versatile molecular imaging 
techniques, which could provide significant guidance for tumor staging and therapy, 
and for evaluation of tumor metastasis. Currently available techniques for imaging of 
tumor vasculature include X-ray computed tomography (CT) and magnetic resonance 
angiography (MRA) due to their unlimited penetration depth and high spatial 
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resolution.[9, 10] They usually take long time to acquire high-quality images or process 
the images acquired,[11] however. A complementary method is the newly developed 
intravital short-wavelength infrared (SWIR, 1000 – 2300 nm) fluorescence imaging, 
which can provide real-time dynamic feedback.  
The SWIR fluorescence imaging has shown improvements in penetration and in 
overcoming tissue autofluorescence, with the rapid development of near-infrared 
fluorescent probes, especially those with emissions in the second near-infrared 
biological window (NIR II) from 1000 nm to 1700 nm.[12-14] A number of NIR II 
nanoprobes, such as single-walled carbon nanotubes (SWNTs),[15, 16] Ag2S and 
core-shell-shell InAs@CdSe@CdS quantum dots (QDs),[17-19] and small-molecular 
dyes,[20-22] have been successfully applied for in-vivo imaging of vasculature, which 
suggests the great potential of NIR II fluorescence imaging in visualization of tumor 
vasculature. 
Recently, lanthanide-doped nanocrystals (NCs) with downconversion luminescence 
in the NIR II window have become a promising nanotheranostic agent due to their 
narrow band emission, deep penetration, long emission lifetime, excellent 
photostability, and low toxicity.[23, 24] The lanthanide NCs sensitized by Yb3+ or Nd3+ 
ions are capable of generating narrow SWIR emission with a large Stokes shift.[25-28] 
For Yb3+ ion-sensitized rare-earth NCs, which are commonly excited by a 
continuous-wave 980 nm laser, the Yb3+ ions absorb the laser photon energy and then 
transfer it to activators (e.g., Er3+, Tm3+, and Ho3+ ions). Due to the fact that 
overheating caused by 980-nm irradiation could damage healthy tissues and reduce 
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the depth of penetration,[29] excitation at ~800 nm is favored due to the low absorption 
of biological tissue at this wavelength. In this context, Nd3+-based rare-earth NCs are 
more attractive, because Nd3+ ions can simultaneously serve as sensitizers and 
activators, whether they are in the form of dopants[30-32] or host matrix.[33] They can be 
excited at ~800 nm to produce narrow SWIR emissions at ~1050 nm (4F3/2 → 
4I11/2) 
and ~1300 nm (4F3/2 → 
4I13/2) for NIR II fluorescence imaging. Previous studies have 
demonstrated that Nd3+ ions were mainly used as dopants, and the optimal molar ratio 
for doping is around 5%, as more Nd3+ ions could cause a quenching effect and 
reduce the photoluminescence efficiency.[34-36] Most Nd3+-doped rare-earth NCs were 
applied for in-vivo NIR imaging with deep penetration,[27, 37, 38] cancer theranostics,[39, 
40] and monitoring of gastrointestinal drug-release.[24]  
From perspective of application, it is extremely important to construct core-shell 
nanostructure, e.g., Nd3+-doped core-shell rare-earth NCs, in order to improve their 
luminescence and attenuation to X-rays, and to introduce other properties such as 
magnetism. The core-shell rare-earth NCs have been usually prepared by a successive 
layer-by-layer (SLBL) approach[41-43] or by ripening-mediated epitaxial growth,[44, 45] 
in both of which small molecular precursors [e.g., lanthanide oleate (Ln-OA), 
lanthanide trifluoroacetate (Ln-TFA), and sodium trifluoroacetate (Na-TFA)], or the 
sacrificed nanoseeds were prepared at high temperature in advance. The reaction 
parameters during synthesis must be finely tuned in order to obtain monodisperse NCs, 
because the fast decomposition of molecular precursors at high temperature could 
result in a burst of nucleation, which is difficult to be separated from growth process 
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and leads to a broad particle size distribution.[46-48] Therefore, development of robust 
approaches for fabrication of high-quality multifunctional core-shell NCs for imaging 
of tumor vasculature is highly significant. 
In this article, an ultra-small nanocluster mediated method was developed to 
prepare a series of Nd3+-doped core-shell NCs with uniform size and morphology, 
from NaYF4, NaNdF4 and NaGdF4 nanoclusters, which serve as precursors for core, 
dopant and shell. Among the resultant core-shell NCs, NaYF4:5%Nd@NaGdF4 NCs 
exhibit the brightest luminescence in the NIR II window, strong 
temperature-dependent paramagnetism and fast attenuation towards X-rays. They 
were selected for NIR II imaging of breast tumor, which grew for different days after 
subcutaneous inoculation of 4T1 cells. The imaging results and the histological 
analyses clearly show the variation of tumor vasculature during the evolution of tumor 
from tumorigenesis, growth, to necrosis. Their potential in visualization of tumor 
vasculature by the NIR II fluorescence imaging was also demonstrated with an 
orthotopic breast tumor. They were also proved to be an excellent agent for MRI 
imaging and CT imaging of tumor. 
 
2. Materials and methods 
2.1. Materials  
Gadolinium (III) chloride hexahydrate (GdCl3·6H2O, 99.9%), yttrium (III) chloride 
hexahydrate (YCl3·6H2O, 99.99%), neodymium (III) chloride hexahydrate 
(NdCl3·6H2O, 99.9%), sodium fluoride (NaF, 99.99% ), oleic acid (OA, 85%) and 
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1-octadecene (ODE, 90%) were purchased from Aladdin Co. Ltd. Sodium hydroxide 
(NaOH, 96%) was obtained from Beijing Chemical Reagents Co. Ltd. 
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene 
glycol)-2000] (DSPE-PEG2000) was purchased from Shang Hai Ponsure Biotech, Inc. 
All chemicals were used as received without further purification. 
2.2. Preparation of nanocluster precursors and nanocrystals 
2.2.1. Preparation of ultra-small lanthanide fluoride (NaLnF4) nanoclusters as 
precursors  
The liquid-solid-solution (LSS) strategy[49, 50] was employed to prepare ultra-small 
lanthanide fluoride nanocluster precursors. In a typical synthesis, 1 mL yttrium (III) 
chloride hexahydrate aqueous solution (0.5 mol/L) and 4 mL sodium fluoride solution 
(0.5 mol/L) were added dropwise to a mixture of sodium hydroxide (1.2 g), ethanol (8 
mL), deionized water (4 mL), and oleic acid (20 mL). The resultant solution was 
thoroughly stirred for 1 h at room temperature to form a yellowish solution, which 
was precipitated with ethanol to collect NaYF4 nanoclusters. The obtained NaYF4 
nanoclusters were washed with ethanol several times, and then dispersed in 2 mL 
cyclohexane for further use. 
The synthesis and purification of NaGdF4 and NaNdF4 nanoclusters are similar to 
NaYF4 nanoclusters, except the replacement of YCl3 with GdCl3 or NdCl3. 
2.2.2. Synthesis of NaREF4:5%Nd (RE = Gd, Y) NCs 
NaREF4 (RE = Gd, Y) nanoclusters were dispersed in 2 mL cyclohexane (0.25 
mol/L) and then mixed with 6 mL oleic acid and 10 mL 1-octadecene in a 100 mL 
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three-neck flask. The flask was purged with nitrogen at 70 °C for 30 min to fully 
remove the cyclohexane, and then heated to 280 °C at a rate of ~10 °C/min. After the 
mixture reacted for 30 min at 280 °C, 420 μL of NaNdF4 nanocluster solution (0.0625 
mol/L) was injected into the mixture and reacted for another 30 min. The reaction 
mixture was cooled to room temperature and centrifuged at 11000 rpm for 10 min, 
after which, the resultant precipitates were washed with absolute ethanol and then 
dispersed in chloroform. 
2.2.3. Synthesis of NaREF4:5%Nd@NaREF4 (RE = Gd, Y) core-shell NCs  
The precursors for growth of shell are NaGdF4 or NaYF4 nanoclusters, which were 
dispersed in 2 mL cyclohexane (0.25 mol/L) and then mixed with 6 mL oleic acid and 
10 mL 1-octadecene. The core NCs (NaGdF4:5%Nd or NaYF4:5%Nd) were prepared 
from the NaLnF4 nanoclusters as described previously. The reaction mixture of core 
NCs was cooled to 30 °C, and 0.5 mmol NaGdF4 or NaYF4 nanocluster solution was 
added. The flask was purged with nitrogen at 70 °C for 30 min to fully remove the 
cyclohexane, and the reaction solution was heated to 280 °C at a rate of ~10 °C/min 
and reacted for 1 h. After the reaction mixture was cooled to room temperature, it was 
centrifuged at 11000 rpm for 10 min to collect core-shell NCs, which were washed 
with absolute ethanol and finally dispersed in chloroform. 
2.3. Modification of core-shell NaYF4:5%Nd@NaGdF4 NCs with phospholipids  
A chloroform solution of oleic acid capped NaYF4:5%Nd@NaGdF4 core-shell NCs 
(0.5 mL, 0.05 mmol) was mixed with another chloroform solution of phospholipid (2 
mL, 12.5 mg) in a screw-neck glass vial. The chloroform was slowly evaporated at 
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room temperature for 24 h in a fume hood. The obtained film was heated at 75 °C for 
5 min to completely remove the chloroform, and then dissolved in 5 mL Milli-Q 
water under sonication for 1 min and stirred vigorously for 10 min at 75 °C. The 
aqueous solution was transferred into a microtube and centrifuged at 20000 rpm for 
10 min. After removal of the supernatant, 2 mL physiological saline (0.9 wt% NaCl) 
was added to dissolve the precipitates, and the solution was centrifuged at 5000 rpm 
for 5 min to remove the large aggregates. The resulting solution was filtered with a 
0.22 μm membrane and stored at 5 °C for further use. 
2.4. Characterization  
TEM images were captured with a FEI Tecnai G20 transmission electron 
microscope operating at an acceleration voltage of 200 kV. The high-resolution TEM 
and high-angle annular dark field − scanning TEM (HAADF-STEM) images were 
collected with a JEOL JEM-2010F. The fluorescence spectra were recorded on a 
FLS980 spectrometer (Edinburgh Instruments, UK) equipped with 808-nm and 
980-nm continuous-wave (CW) laser diodes (2 W), which served as the excitation 
sources. The hydrodynamic size was measured at 25 °C with a Malvern Zetasizer 
Nano ZS90 equipped with a solid state He–Ne laser (λ = 633 nm). The crystal 
structures of nanoparticles were characterized with a Shimadzu XRD-6000 X-ray 
diffractometer equipped with Cu Kα1 radiation (λ = 0.15406 nm). 
2.5. Cytotoxicity assay  
The standard MTT assay was performed to evaluate the cytotoxicity of core-shell 
NCs towards cancer cells. 4T1 cells (1 × 104 cells per well) were first seeded into 
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96-well plates and cultured for 24 h in a standard cell medium at 37 °C in 5% CO2 
atmosphere. Then, these cells were washed with PBS and incubated with 
DSPE-PEG2000 modified core-shell NaYF4:5%Nd@NaGdF4 NCs in different 
concentrations (6.25, 12.5, 25, 50, 100, 200, and 400 μg/mL) for 24 h. After that, the 
cells were washed with PBS, and 20 μL MTT 
[(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)] solution (5 mg/mL) 
was added and incubated with the cells for 4 h before the addition of 150 μL dimethyl 
sulfoxide (DMSO). The absorbance of each solution at 490 nm was measured by a 
microplate reader (Thermo, Varioskan Flash). 
2.6. Animal model  
Specific pathogen free (SPF) grade BALB/c female mice were purchased from 
Shanghai SLAC Laboratory Animal Co., Ltd. and used under protocols approved by 
the Laboratory Animal Center of Soochow University. The tumors used to investigate 
their evolution were grafted by subcutaneous inoculation of 2 × 106 4T1 cells (in 
about 50 μL PBS) into the right flank region on the back of each mouse. The 
orthotopic breast tumor was similarly grafted into the right side of the third-pair 
mammary gland of the mouse. 
2.7. Blood circulation behavior of core-shell NaYF4:5%Nd@NaGdF4 NCs  
Five healthy BALB/c mice were intravenously injected with the core-shell NCs at a 
dosage of 20 mg/kg. Blood samples were drawn from their eye sockets at different 
time points of post injection, i.e., 3 min, 10 min, 30 min, 1 h, 2 h, 4 h, 8 h, 12 h, 24 h 
and 48 h. The contents of Gd in the blood samples were measured by inductively 
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coupled plasma–mass spectroscopy (ICP-MS) after they were digested with a mixture 
of HNO3 and H2O2 (HNO3/H2O2 = 2:1 by volume). The decay curve of Gd contents in 
the blood was fitted with an exponent quadratic model. 
2.8. NIR II fluorescence imaging  
In-vivo NIR II fluorescence imaging was performed with a NIR II Imaging System 
(Serious II 900 – 1700) manufactured by Suzhou NIR-Optics Co., Ltd. (China). The 
power density of 808-nm laser was set to 45 mW/cm2, and all NIR II images were 
collected with an exposure time of 150 ms. The mice were anaesthetized by 
intraperitoneal injection of 1% pelltobarbitalum aqueous solution (125 µL). After 
pre-contrast images were collected, the anaesthetized mice were intravenously 
injected with a physiological saline solution of DSPE-PEG2000 modified 
NaYF4:5%Nd@NaGdF4 NCs (8 mg/mL, 150 μL), followed by the acquisition of NIR 
II photoluminescence images at different time points. 
2.9. MRI imaging 
 In-vitro MRI imaging was performed with a 0.5 T MRI scanner (NMI20-015V-I). 
The longitudinal relaxivity (i.e., r1) of NaYF4:5%Nd@NaGdF4 NCs was measured 
from a series of solutions with different concentrations of Gd3+ (0.4, 0.8, 1.6, 3.2, 6.4 
mM). The in-vitro T1- weighted MRI images were also collected. The in-vivo MRI 
imaging was performed on a 1 T MRI scanner (NM42-040H-I) after the mice were 
anesthetized with isoflurane. The in-vitro and in-vivo imaging instruments were 
provided by Suzhou Niumag Analytical Instrument Corporation.  
2.10. CT imaging  
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The performance of modified core-shell NCs as a contrast agent for CT imaging 
was compared with that of core nanoparticles. They were dissolved in aqueous 
solutions with concentrations of 0, 0.94, 1.88, 3.75, 7.5, 15 mM, respectively. For 
in-vivo CT imaging, the tumor-bearing mice were anesthetized with isoflurane, and 
then intravenously injected with 200 μL core-shell NaYF4:5%Nd@NaGdF4 NC saline 
solution (12 mg/mL). The mice were anesthetized with isoflurane throughout the 
imaging process. The images were scanned in an accurate mode using full angle, 3 
frame averaging, a 615 mA tube current, and 55 kV tube voltage. 
2.11. Histological analysis  
To assess the histology of tumor tissues from different growth time (i.e., 1 day, 4 
days, 8 days and 12 days), all tumors were harvested after the completion of NIR II 
imaging, and then fixed in 10% neutral buffered formalin, processed routinely into 
paraffin, sectioned into thin slices, and stained with H&E for histological analysis. To 
assess the influence of administrated core-shell NCs on the healthy mice, their major 
organs (heart, liver, spleen, lung, kidney) were harvested on day 10 after the mice 
were intravenously injected with core shell NCs, and then treated with the same 
procedure for histological analysis. 
2.12. Hemanalysis  
  Four groups of healthy BALB/c mice were intravenously injected with 
NaYF4:5%Nd@NaGdF4-DSPE-PEG2000 NCs with a dose of 20 mg/kg, and then 
sacrificed on day 1, day 7, day 10 and day15 respectively, to collect blood samples for 
analysis. All blood samples were tested to obtain the hemanalysis data including the 
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blood routine and blood chemistry. The results are compared with those from mice in 
the control group. 
 
3. Results and discussion 
3.1. Ultra-small nanocluster mediated synthesis of Nd3+-doped core-shell NCs 
Ultra-small NaLnF4 nanoclusters, where Ln is a lanthanide ion (i.e., Ln = Y, Gd, 
and Nd), were prepared by the versatile LSS method[49, 50] through phase transfer and 
separation processes at room temperature, which is contrast to hot-injection of 
molecular precursors or sacrificed nanoseeds in homogenous phase at high 
temperature.[27, 41-45, 51] They were employed as precursors for the core, dopant, and 
shell to synthesize monodisperse Nd3+-doped core-shell NCs with bright NIR II 
luminescence through a one-pot reaction (Scheme 1a).  
NaYF4 and NaGdF4 were selected as the core- and shell materials because of their 
relatively low phonon energy[52] and the minimal lattice mismatch (< 2%) between 
them (Table S1 in the Supporting Information).[44, 53] First, the purified NaYF4 (or 
NaGdF4) nanoclusters were dissolved in a high boiling-point solvent (i.e., 
1-octadecene, ODE) and heated to 280 °C to grow into large NaYF4 (or NaGdF4) core 
NCs. Then, NaNdF4 nanoclusters were injected into the core solution to form 
Nd3+-doped NaYF4 (or NaGdF4) NCs. After that, NaGdF4 (or NaYF4) nanoclusters 
were injected into the reaction mixture to form the uniform core-shell NCs. In contrast 
to the well-known nucleation-growth mechanism of NCs prepared by hot-injection of 
molecular precursors, the use of nanoclusters can avoid the burst of nucleation and the 
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influence of by-products generated from decomposition of molecular precursor, and 
can result in core-shell NCs with a narrow size distribution.[54-56]  
3.2. Characterization of Nd3+-doped NCs 
The obtained core-shell NCs were characterized by various facilities to reveal their 
size, morphology, structure, components, and properties. TEM images of core NCs 
(NaYF4:5%Nd), shell precursor (NaGdF4 nanoclusters), and core-shell 
NaYF4:5%Nd@NaGdF4 NCs are shown in Figure 1a-c. For comparison, the TEM 
image of a mixture of NaYF4:5%Nd core NCs and shell precursor is also presented in 
Figure S1a. The corresponding size distributions of core, shell and core-shell 
nanoparticles in Figure S1b demonstrate an obvious change of particle size after 
growth of NaGdF4 shell. The favorable growth of ultra-small NaGdF4 nanoclusters 
[(2.0 ± 0.4) nm] on the surface of larger cores[45, 54, 55] led to around 9 nm increments 
in the size of final core-shell NCs (Figure S2a, b). High-angle annular dark field – 
scanning TEM (HAADF-STEM) and high-resolution STEM images of 
NaYF4:5%Nd@NaGdF4 NCs (Figure 1d, e) clearly show the core-shell nanostructure 
with distinct contrast between the core and shell. The elemental mappings (Figure 1f, 
g) and the line scan spectra from energy-dispersive X-ray spectroscopy (EDS) of a 
single core-shell NC (Figure 1h) confirm the Y-based core and Gd-based shell, 
respectively. The lattice spacings for the core and shell shown in a typical 
high-resolution TEM image (Figure 1i) are ∼2.91 Å and ∼5.16 Å, respectively, 
matching well with the (101) planes of NaYF4 and the (100) planes of NaGdF4. The 
sharp and resolved X-ray diffraction (XRD) peaks in Figure S4a further demonstrate 
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the good crystallinity of core-shell NCs due to high reaction temperature. 
The above characterization results demonstrate the successful preparation of 
monodisperse core and core-shell NCs (i.e., NaYF4:5%Nd and 
NaYF4:5%Nd@NaGdF4) through our nanocluster-mediated one-pot synthetic 
approach. A number of monodisperse Nd3+-doped downconversion NCs (e.g., 
NaYF4:5%Nd@NaYF4, NaGdF4:5%Nd, NaGdF4:5%Nd@NaYF4, and 
NaGdF4:5%Nd@NaGdF4) were prepared (Figure S2c-f) by using different 
combinations of NaYF4, NaGdF4, and NaNdF4 nanoclusters. The high-resolution 
TEM and HAADF-STEM image of NaGdF4:5%Nd@NaYF4 NCs (Figure S3) further 
illustrate the successful preparation of core-shell nanostructure, in which the core size 
(9.1 nm) matches well with that of NaGdF4:5%Nd NCs (9.5 ± 0.6) nm in Figure S2d. 
The bright core and grey shell observed in the HAADF-STEM image is attributed to 
the huge difference in the atomic number of Gd (Z = 64) and Y (Z = 39). The uniform 
size and morphology of the resultant core-shell NCs are attributed to the separation of 
the nucleation from the growth processes and the minimal lattice mismatch (< 2%) 
between NaYF4 and NaGdF4 (Table S1). The small deviation of main peaks in their 
XRD patterns (Δ2θ < 3°, Figure S4a, b) further illustrates the small lattice mismatch 
between the core and the shell. 
All the resultant Nd3+-doped core-shell NCs exhibit bright photoluminescence, 
especially the core-shell NCs. Four types of Nd3+-doped core-shell NCs (i.e., 
NaYF4:5%Nd@NaYF4, NaYF4:5%Nd@NaGdF4, NaGdF4:5%Nd@NaGdF4, and 
NaGdF4:5%Nd@NaYF4) were selected to investigate their optical properties. They 
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exhibit similar UV-Vis-NIR absorbance due to their similar structure and 
compositions, although their photoluminescence intensity in the NIR II window is 
quite different. To quantify their relative photoluminescence quantum yields (QYs), 
inductively coupled plasma − atomic emission spectrometry (ICP-AES) was used to 
determine concentrations of Gd3+ and Y3+ ions. The molar concentration of these 
core-shell NCs was set at 0.1 mol/L to allow comparison of their downconversion 
luminescence under 808 nm excitation. Their photoluminescence spectra in Figure 
S4c clearly show that the NaYF4:5%Nd@NaGdF4 NCs possess the strongest 
luminescence. To further verify it, their relative photoluminescence QYs were 
quantified by using the standard NIR dye IR-26 as a reference, which has a QY of 0.5% 
under 785 nm excitation.[57] The UV-Vis-NIR absorbance spectra of these core-shell 
NCs in cyclohexane and their photoluminescence spectra, together with that of IR-26 
in dichloroethane under 785 nm excitation, are shown in Figure S4d-f. The 
absorbance of IR-26 at 785 nm (As) and the integral area of its fluorescence under 
excitation at 785 nm (Fs) were characterized as 0.061 and 5.75 × 10
-10. The 
absorbance of these core-shell NCs at 785 nm (Au) and the integral areas of their 
fluorescence under excitation at 785 nm (Fu) are listed in Table S2. Although 785 nm 
is not the optimal excitation wavelength for Nd3+-doped NCs[37, 38] and the integral 
area only covers the emission in the NIR II region, it is sufficient to verify which type 
of NCs possess the strongest luminescence. Their relative QYs were calculated by the 
equation [QYu = QYs*(Fu/Fs)*(As/Au)*(Gu/Gs)
2], in which Gu and Gs are the refractive 
indices of the solvents for the NCs and the IR-26. The results in Table S2 show that 
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NaYF4:5%Nd@NaGdF4 NCs have a relative QY of 0.52%, which is the highest 
among core-shell NCs and comparable to that of the standard dye IR-26. The bright 
luminescence could be attributed to the core-shell structure. For the same type of 
core-shell NCs prepared under the same conditions and from the same cores,[58] the 
thicker shell could effectively reduce the surface quenching effect than the thinner 
shell, and lead to the stronger luminescence.[46] Although the relative QY of our NCs 
is lower than that of ligand-free NaGdF4:Nd
3+@NaGdF4 NCs, they are bright enough 
for the NIR II imaging of tumor.[37] 
In addition to the bright NIR II luminescence, these core-shell NCs exhibit 
interesting magnetism[59] and attenuation towards X-rays,[60] which make them 
promising not only for NIR II fluorescence imaging, but also for MRI and CT 
imaging. Therefore, core-shell NaYF4:5%Nd@NaGdF4 NCs with the highest relative 
QY were modified with 
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene 
glycol)-2000] (DSPE-PEG2000)
[61] for imaging the vasculature of tumors during their 
progression through multimodal imaging (Scheme 1b). The Fourier transform infrared 
(FTIR) spectrum of the DSPE-PEG2000 modified NCs (red line) is compared with 
those of pure DSPE-PEG2000 (blue curve) and oleic acid capped 
NaYF4:5%Nd@NaGdF4 NCs (black curve) in Figure S5a. The characteristic vibration 
of C-O-C bond at ~1100 cm-1 from the PEG fragment of DSPE-PEG2000 are clearly 
observed in the modified core-shell NCs, which demonstrates the successful surface 
modification through the hydrophobic-hydrophobic interactions between oleic acid 
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and DSPE-PEG2000. 
The hydrodynamic size of modified NaYF4:5%Nd@NaGdF4 NCs in the saline 
solution (0.9 wt% NaCl) was determined to be 48.6 nm by the dynamic light 
scattering (DLS) method (Figure 2a), and was fluctuated around 50 nm over a week, 
which suggests their excellent colloidal stability after modification with 
DSPE-PEG2000 (Figure S5b). Their fluorescence intensity at 1060 nm was decreased 
by nearly 2.9 times after surface modification (Figure S5c), but it is 16 times stronger 
than hydrophilic NaYF4:5%Nd core NCs at the same molar concentration (Figure 2b). 
Their CT value is also 3.5 times stronger than modified core NCs (Figure 2c). These 
results demonstrate the significance of growing NaGdF4 shells on core NCs. The shell 
not only effectively reduced the surface defects to enhance downconversion 
luminescence, but also improved X-ray attenuation capability due to the higher atomic 
number of gadolinium (Z = 64) than that of yttrium (Z = 39).  
The core-shell NaYF4:5%Nd@NaGdF4 NCs also exhibit paramagnetism with a 
small value of 2.48 emu/g at 300 K and a larger value of 67.92 emu/g at 5 K (Figure 
2d). The dependence of proton relaxation on the concentration of core-shell 
NaYF4:5%Nd@NaGdF4 NCs was evaluated by using a 0.5 T MRI scanner. As shown 
in Figure 2e, the longitudinal relaxation is linearly increased with Gd3+ concentration, 
and the relaxivity (r1) is calculated to be 0.89 mM
−1s−1 at 0.5 T, which indicates their 
great potential in T1-weighted MRI imaging. 
3.3. Biocompatibility and safety of Nd3+-doped core-shell NCs 
It is well known that phospholipids, as the major component of cell membrane, 
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exhibit excellent biocompatibility.[62, 63] Prior to the in-vivo bioimaging, the potential 
cytotoxicity of DSPE-PEG2000 modified NaYF4:5%Nd@NaGdF4 NCs towards 4T1 
cells (murine breast cancer cells) was evaluated by the standard MTT assay. Figure 2f 
shows that the cell viabilities exceed 87%, even when the concentration of rare-earth 
ions (Gd3+ + Y3+) is as high as 400 µg/mL, owing to the phospholipid surface 
modification.  
The MTT results demonstrate the in-vitro excellent biocompatibility of modified 
NaYF4:5%Nd@NaGdF4 NCs. To investigate their in-vivo biocompatibility and 
biosafety, four groups of healthy BALB/c mice were intravenously injected with 
NaYF4:5%Nd@NaGdF4-DSPE-PEG2000 NCs at a dose of 20 mg/kg, and then were 
sacrificed on day 1, day 7, day 10 and day15 respectively, to collect blood samples for 
blood routine examination and blood biochemistry analysis, as hematological factors 
can reflect the inflammatory responses caused by any side effects of a foreign 
substance.[64] The blood indexes (Figure 3a-f) include hemoglobin (HGB), red blood 
cells (RBC), white blood cells (WBC), hematocrit (HCT), platelet (PLT), and mean 
corpuscular volume (MCV). There is no significant difference in RBC, HGB, MCV 
and HCT between the mice from the control group and experimental group. The slight 
decrease in WBC and slight increase in PLT in the mice from the experimental group 
on day1 and day 7, and then recovery to the similar level of mice in the control group 
indicate a mild immunological stress.  
Serum biochemical analysis (Figure 3g-l) was carried out to show the total protein 
(TP), albumin (ALB), globulin ratio of albumin (GLOB), ratio of albumin to globulin 
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(A/G), aspartate aminotransferase (AST), urea nitrogen (UREA). The slight decrease 
in TP and GLOB in the mice from the experimental group on day 1 suggests a 
disorder of immune system or a potential inflammation. Although AST and UREA, 
the important markers of liver function and kidney function, are slightly fluctuated, 
they are rather comparable with those of mice from the control group. The recovery of 
all indicators in the blood collected on day 10 suggests less toxicity of these core-shell 
NCs.  
To further demonstrate the biosafety of our NCs, we further carried out 
hematoxylin and eosin (H&E) staining of major organs including heart, liver, spleen, 
lung and kidney. The images in Figure 3m and Figure S6 show that the structural 
patterns of these organs harvested on day 10 from mice in the experimental group are 
similar to those of mice from the control group. 
The blood circulation behavior of NaYF4:5%Nd@NaGdF4-DSPE-PEG2000 NCs 
was assessed by determining the contents of Gd in the blood samples with ICP-MS. 
As shown in Figure S7, the blood half-life time is calculated to be 5.9 h by fitting the 
blood circulation profile with an exponent quadratic model. The long blood half-life 
indicates their remarkable stability in the blood environment, and ensures their 
distribution in different organs and tissues for imaging.  
3.4. In-vivo multimodal imaging of vasculature in subcutaneous breast tumor 
Compared with upconversion NCs, an advantage of NaYF4:5%Nd@NaGdF4 NCs 
is their downconversion luminescence in the NIR II region, which features a higher 
signal-to-noise ratio and deeper penetration in comparison with visible luminescence. 
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To demonstrate their feasibility in the NIR II imaging, a physiological saline solution 
of NaYF4:5%Nd@NaGdF4-DSPE-PEG2000 NCs (8 mg/mL, 150 μL) was 
intravenously injected into a healthy mouse, and then NIR II photoluminescence 
images (Figure S8) were acquired at different time points under excitation of an 
808-nm laser. The power density of laser was 45 mW/cm2, and the exposure time was 
150 ms. Compared with the pre-contrast image, the liver contour and major blood 
vessels (labeled with red and white arrows, respectively) are clearly observed. In 
addition, the liver became brighter and brighter due to the gradual accumulation of 
NCs in liver. This control experiment demonstrates the feasibility and potential of our 
bright core-shell NCs in visualizing the vasculature and major organs of a mouse. 
  As stated previously, tumor vasculature has played significant roles in 
tumorigenesis, growth, necrosis, and metastasis. In order to visualize the evolution of 
tumor vasculature in living mice, 4T1 tumor cells (2 × 106) in phosphate buffered 
saline (PBS) solution were subcutaneously injected into the flank region of the right 
back of living BALB/c mice, which were cultured for different days to obtain 
different sized tumors. Then DSPE-PEG2000 modified NaYF4:5%Nd@NaGdF4 NCs (8 
mg/mL, 150 μL) were intravenously injected into tumor-bearing mice to 
macroscopically visualize their tumor vasculature. In contrast to imaging the tumor 
vasculature from the same mouse,[7, 11] or imaging a certain-sized tumor with 
well-established vasculature,[9] this approach could avoid the influence of in-vivo 
retention of NCs (e.g., in the tumor and in other major organs) on tumor growth, and 
could obtain the clear tendency of tumor progression through multimodal imaging. 
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Tumor-bearing mice were divided into four groups by the time-course of tumor 
growth, or by the three stages of tumor progression as illustrated in Scheme 1b (i.e. 
tumor angiogenesis, growth, and necrosis). Figure 4a and Figure S9 shows the NIR II 
fluorescence images of tumors grown for different days after subcutaneous 
inoculation of 4T1 cells. It is difficult to see mice in all pre-contrast images due to the 
low bio-fluorescence of mice in the NIR II window (Figure S9). After administration 
of core-shell NCs, they become visible in the NIR II images due to the strong 
fluorescence from NCs. For the tumor grown for only 1 day (Figure 4a, day 1), there 
is a dark spot (red dashed circle) in the NIR II fluorescence images acquired at 1 min, 
10 min, 20 min, and 30 min post injection of core-shell NaYF4:5%Nd@NaGdF4 NCs. 
The dark spot is the site where tumor cells were inoculated, and means the absence of 
neo-vasculature within it. The fluorescence from the periphery of dark spot was 
clearly observed 1 min after injection, and the contrast was gradually enhanced with 
the circulation of NCs. More importantly, the neo-vasculature (pointed by white 
arrows) connected with the dark spot is clearly observed. 
The photograph in Figure 5a1 also shows that in comparison with healthy mouse in 
Figure S10a, a tiny lump with a volume of 36.6 mm3 (calculated from the equation V 
= ab2/2, a = 5.09 mm, b = 3.79 mm) was developed within 24 h after the injection of 
tumor cells. The intense hyperemia at the injection site[65] could explain the notable 
contrast between the lump and its periphery in the NIR II images. To further 
understand this phenomenon, the hematoxylin and eosin (H&E) staining of 
longitudinal section of epidermal tissue from healthy mouse (Figure S10b-d) and the 
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lump (Figure 5b) were performed. A slight increment in the abundance of blood 
vessels in derma is observed. Moreover, an obvious dilatation of capillaries (labeled 
with red arrows in Figure 5b), which is consistent with the macroscopic hyperemia 
phenomenon around inoculation area, demonstrate the proliferation of tumor cells 
(black dashed area in Figure 5b1).
[65] Although highly concentrated Nd3+-doped NCs 
could produce heat upon irradiation with the high-power-density laser,[66] the heating 
effect of our Nd3+-doped NCs on the normal skin and tumor tissue is negligible due to 
the low dopant concentration and low power density of laser (45 mW/cm2) during the 
imaging process. 
On day 4 after inoculation of tumor cells, the hyperemia at the inoculation site has 
disappeared, and the tumor (Figure 5a2) remains the similar size (V = 34.7 mm
3, a = 
4.64 mm, b = 3.87 mm) in comparison with that developed after inoculation for 1 day 
(Figure 5a1, 36.6 mm
3). After intravenous injection of core-shell 
NaYF4:5%Nd@NaGdF4 NCs, the major vessels (pointed by white arrows) around the 
tumor are clearly observed 1 min post injection (Figure 4a, day 4). With the 
circulation of NCs and their infiltration into tumor (red dashed circle), the tumor 
gradually became bright, and the tumor-to-background ratio is steadily enhanced 
within 20 min post injection (Figure 4b). The tumor-to-background ratio is calculated 
by the ratio between the average signal of tumor and the average noise of 
background.[7] Although this ratio calculated from the results obtained at 30 min is 
only 0.58 lower than that obtained at 20 min, the contrast between the tumor and its 
periphery is much clearer due to the decrease of NCs from the surrounding vessels. 
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Unlike the absence of vasculature in the tumor grown for 1 day, the above imaging 
results illustrate the formation of neo-vasculature within tumor at this stage. In 
addition, the observed surrounding vessels are also more than those observed in tumor 
grown for 1 day.  
To further confirm the formation of neo-vasculature within tumor, the tumor was 
dissected and sliced in the longitudinal direction for H&E staining. The images in 
Figure 5c clearly shows that the derma has become much thinner, accompanied by a 
decrease in the vessels in comparison with those in Figure 5b, mainly due to the 
invasion of tumor cells. In addition, many different sized vessels are found in loose 
tumor tissue (Figure 5c1), which are responsible for the infiltration and retention of 
NCs in tumor. 
When the tumor has grown for 8 days to achieve a size around 5 fold larger (Figure 
5a3, V = 166.7 mm
3, a = 7.94 mm, b = 6.48 mm) than that grown for 4 days. NIR II 
images were collected at the same time intervals after intravenous injection of 
core-shell NC solution (Figure 4a, day 8). In contrast to the results of NIR II imaging 
of tumor grown for 4 days, the fluorescence from the whole tumor area (red dashed 
circle) is rapidly enhanced after intravenous injection of NCs, and the 
tumor-to-background ratio is nearly 1.9 fold higher than that from the tumor grown 
for 4 days (Figure 4b). Since there is no obvious increase in neo-vasculature around 
the tumor area (white arrow pointed), the stronger signal is attributed to the abundant 
well-established vasculature within the tumor. This result is supported by the H&E 
staining of a longitudinal section of tumor in Figure 5d, which reveals an abundance 
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of capillaries and increasing compactness of tumor compared with that excised on day 
4.  
After the tumor grew for 12 days, the tumor was necrotized to form escharosis 
(Figure 5a4), due to the insufficient supply of nutrients and oxygen during the 
proliferation of tumor cells, and the same NIR II imaging procedure was performed to 
reveal the signal enhancement around the tumor (Figure 4a, day 12). The whole tumor 
area and its escharosis region are labeled with red- and white dashed circles 
respectively, and their tumor-to-background ratios are shown in Figure 4c. Although 
the major vessels (pointed by white arrow) are still visible, the continuous decline of 
their tumor-to-background ratios indicate the difficult circulation and retention of NCs 
within tumor, which is very likely due to the angionecrosis in the tumor and the 
formation of escharosis.  
The angionecrosis in the tumor is confirmed by the results from H&E staining of 
tumor longitudinal sections (Figure 5e). Massive erythrocytes are effused from broken 
vessels, and diffused with inflammatory cells and necrotic cells, as shown in Figure 
5e1 and Figure 5e3. The angionecrosis in the tumor and the formation of escharosis 
suggest the possible occurrence of tumor metastasis at this stage, as earlier studies 
have revealed that subcutaneous 4T1-tumor-bearing mice with serious escharosis had 
obvious tumor metastasis to major organs like lung and liver.[60, 67] 
Although the NIR II imaging features noninvasive real-time feedback with high 
sensitivity,[12, 18] it has limited penetration in comparison with MRI and CT imaging. 
As demonstrated in Figure 2, core-shell NaYF4:5%Nd@NaGdF4 NCs have great 
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potential in MRI and CT imaging due to their room-temperature paramagnetism and 
their capability of attenuating X-rays. Since the tumor grown for 8 days (with a size of 
166.7 mm3) has well-established vasculature, MRI and CT imaging were performed 
on mice bearing such tumors to provide complementary information. Figure 6a 
displays the color-mapped MRI images collected at 20 min, 40 min, and 60 min on a 
1 T MRI scanner, after intravenous injection of NC saline solution (5 mg/mL, 200 μL) 
into a tumor-bearing mouse. Compared with the pre-contrast image, obvious 
enhancement is observed in the tumor longitudinal section (red dashed circle), which 
is consistent with the NIR II imaging results. The in-vivo CT images (Figure 6b) 
further confirm the enhancement in the tumor (white dashed circle) after intravenous 
injection of 200 μL saline solution of core-shell NaYF4:5%Nd@NaGdF4 NCs (12 
mg/mL). The CT values are increased from 25.86 HU for the pre-contrast image to 
46.80 HU for image acquired at 30 min post-injection of NCs (Figure 6c). The results 
obtained from the NIR II fluorescence imaging, MRI, and CT imaging demonstrate 
the potential of core-shell NaYF4:5%Nd@NaGdF4 NCs for multimodal imaging of 
tumor and its vasculature, which is responsible for the circulation and accumulation of 
NCs in tumor tissue. 
3.5. In-vivo NIR II imaging of vasculature in orthotopic breast tumor 
  Since the vasculature of a tumor implanted in the flank region of mouse could be 
different from that of an orthotopic tumor, an orthotopic breast tumor was implanted 
on the right side of the third-pair mammary gland of a mouse for visualization of its 
vasculature through NIR II fluorescence imaging with our core-shell 
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NaYF4:5%Nd@NaGdF4 NCs. The NIR II images of a healthy mouse (Figure 6d1) and 
an orthotopic tumor-bearing mouse (Figure 6d2) were collected after intravenous 
injection of NC solution (8 mg/mL, 200 μL). In comparison with the tumor implanted 
in flank region (Figure 4a), the vessels across tumor surface and those around the 
tumor contour are observed with low contrast, although the corresponding H&E 
staining of its longitudinal section (Figure 6e1) reveals abundant blood vessels in the 
tumor. The observed discrepancy could be attributed to differences in the tumor 
location.[6] In addition, a bright spot (indicated by red arrows in Figure 6d) is clearly 
observed in the right inguinal region in both mice, which is confirmed to be a vascular 
intersection after dissection of them (Figure 6e3, red arrow). These results further 
demonstrate the potential of core-shell NaYF4:5%Nd@NaGdF4 NCs in NIR II 
imaging of vasculature.  
 
4. Conclusion 
In summary, an ultra-small nanoclusters mediated synthetic approach was 
developed to prepare monodisperse Nd3+-doped downconversion nanocrystals. The 
core-shell NaYF4:5%Nd@NaGdF4 NCs exhibit the strongest photoluminescence 
among the resultant NCs for NIR II fluorescence imaging, and possess strong 
paramagnetism and X-ray attenuation for MRI and CT imaging. They were modified 
with DSPE-PEG2k to show long blood circulation half-life (5.9 h), excellent 
biocompatibility and biosafety. They were successfully applied for visualization of 
tumor vasculature by the NIR II imaging in a breast tumor model, which was 
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established by the subcutaneous inoculation of 4T1 cells. The formation and variation 
of tumor vasculature during tumorigenesis, growth and necrosis was clearly observed 
and further confirmed by the histological analysis. The tumor grown for 8 days after 
inoculation has well-established vasculature than other tumors grown for different 
days, demonstrated by the strongest signal obtained during the NIR II imaging, MRI 
imaging and CT imaging. The potential of NIR II fluorescence from our NCs in 
visualization of tumor vasculature was also illustrated in an orthotopic breast tumor 
model. These results are not only crucial for understanding of tumor progression, 
tumor staging, and tumor therapy, but also highlight the great potential of Nd-based 
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Scheme 1. (a) Schematic illustration of the synthesis of NaYF4:5%Nd@NaGdF4 
core-shell NCs, (b) their application in NIR II, MRI, and CT imaging of tumor from 
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tumorigenesis, growth and necrosis.  
 
  
Figure 1. TEM images of (a) NaYF4:5%Nd core NCs, (b) NaGdF4 nanoclusters for 
growth of shell, and (c) core-shell NaYF4:5%Nd@NaGdF4 NCs; (d) HAADF-STEM 
image, (e) high-resolution STEM image, (f, g) element mappings corresponding to (d), 
(h) magnification of (d) with EDS line scans, and (i) high-resolution TEM image of 




Figure 2. (a) Hydrodynamic size of NaYF4:5%Nd@NaGdF4-DSPE-PEG2000 NCs 
dispersed in saline solution (0.9 wt% NaCl); (b) comparison of in-vitro 
downconversion luminescence spectra under 808 nm excitation between 
DSPE-PEG2000 decorated core (NaYF4:5%Nd) and core-shell 
(NaYF4:5%Nd@NaGdF4) NCs (inset: photograph of solutions under 808 nm 
excitation); and (c) in-vitro CT values of DSPE-PEG2000 decorated core and core-shell 
NCs dispersed in physiological saline with same molar concentration gradient (0, 0.94, 
1.88, 3.75, 7.5, 15 mM), with the inset showing photographs of CT images obtained 
from different concentrations; (d) magnetization isotherms of oleic acid coated 
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NaYF4:5%Nd@NaGdF4 NCs at 5 K and 300 K, (e) in-vitro longitudinal proton 
relaxation of NaYF4:5%Nd@NaGdF4-DSPE-PEG2000 NCs with different 
concentrations of Gd3+ (0.4, 0.8, 1.6, 3.2, 6.4) mM, with the inset showing 
T1-weighted MRI images with different concentrations; (f) relative cell viabilities of 











Figure 3. Hemanalysis of BALB/c mice intravenously injected with 
NaYF4:5%Nd@NaGdF4-DSPE-PEG2000 NCs: blood routine test including (a) 
hemoglobin (HGB), (b) red blood cell count (RBC), (c) white blood cell count (WBC), 
(d) hematocrit (HCT), (e) platelets (PLT), (f) mean corpuscular volume (MCV); blood 
biochemical tests including (g) total protein (TP), (h) albumin (ALB), (i) globulin 
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ratio of albumin (GLOB), (j) ratio of albumin to globulin (A/G), (k) aspartate 
aminotransferase (AST), (l) urea nitrogen (UREA). (m) H&E staining of major organs 
of mice from control group and experimental group on day 10, including heart, liver, 
















Figure 4. (a) In-vivo NIR II images of tumors (red dashed cycles) grown for different 
days after subcutaneous inoculation of 4T1 tumor cells; time-course of tumor growth 
covers three stages of tumor angiogenesis, growth, and necrosis; the NIR II images 
clearly shows the formation and variation of tumor vasculature (pointed by white 
arrows). (b-c) Time-dependent tumor-to-background ratios determined by the average 
signal of tumor (red dashed cycles) and the average noise of background (white solid 
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Figure 5. (a) Photographs of mice bearing tumors grown for different days after 
subcutaneous inoculation of 4T1 tumor cells after different numbers of days, and used 
for the NIR II imaging (scale bar: 5 mm), (b-e) H&E staining of corresponding tumor 





Figure 6. (a-b) In-vivo T1-weighted MRI images and CT images of mice bearing 4T1 
tumors, collected before and after intravenous injection of 200 μL 
NaYF4:5%Nd@NaGdF4-DSPE-PEG2000 NCs physiological saline solution at different 
time points, the nanoagent concentrations for MRI and CT imaging are 5 mg/mL and 
12 mg/mL, respectively; (c) corresponding CT signal intensity of tumor sections; (d) 
in-vivo NIR II images of a healthy mouse (d1) and an orthotopic tumor-bearing mouse 
(d2) after intravenous injection of NaYF4:5%Nd@NaGdF4-DSPE-PEG2000 NCs in 
50 
physiological saline solution (8 mg/mL, 200 μL); (e1) H&E staining of tumor 
longitudinal sections (scale bar:100 µm), and corresponding photographs of 
orthotopic breast cancer-bearing mouse (e2) before and after (e3) dissection. The red 
and white arrows point to the vascular intersection and the orthotopic tumor, 
respectively. 
 
